Anaplastic Oligoastrocytoma - 21 Studies Found
| Active, not recruiting |
: Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas : Brain and Central Nervous System Tumors : 2002-04-09 :
|
| Completed |
: A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma :
: 2013-12-16 :
|
| Completed |
: Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial :
: 2013-04-29 : Drug: Temozolomide Temozolomide 200 mg/m2/d in a fasting state for 5 consecutive days (1,000 mg/m2 per 2 |
| Completed |
: A Study on β-elemene as Maintain Treatment for Complete Remission Patients of Newly Diagnosed Malignant Gliomas Following Standard Treatment :
: Drug: β-elemene β-elemene 600mg/d,ivdrip,d1-14,every 28 days for 1 cycle, totally 6 cycles |
| Completed |
: A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas :
: |
| Completed |
: Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA :
|
| Not yet recruiting |
: Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas :
|
| Withdrawn |
: Re-irradiation of High Grade Gliomas: a Quality of Life Study :
|
| Active, not recruiting |
: A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma :
|
| Active, not recruiting |
: Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma :
|